February 2019

This is therefore a comparing of the profitability, analyst recommendations, risk, institutional ownership, dividends, earnings and valuation in Intec Pharma Ltd. (NASDAQ:NTEC) and Moleculin Biotech Inc. (NASDAQ:MBRX). The two are both Biotechnology companies that compete with one another. Valuation and Earnings Table 1 showcases the top-line revenue, earnings per share (EPS) and valuation of Intec […]

by

JERUSALEM, Feb. 28, 2019 /PRNewswire/ — Intec Pharma Ltd. (NASDAQ: NTEC) (“Intec” or “the Company”) today announces that Company management will participate at the following upcoming investment conferences in March.  Cowen 39th Annual Health Care ConferenceDate: March 11-13, 2019Company Presentation: Monday, March 11, 2019 at 2:10 pm (Eastern time) Location: Boston Marriott Copley Place, Boston, MAPresenter: […]

by

Dr. Ethan Russo, neurologist and medical scientist, discusses CBD, clinical endocannabinoid deficiency, and various ways to target the endocannabinoid system for therapeutic benefit.  Transcript Project CBD: Today we’re talking with Dr. Ethan Russo. Dr. Russo, a board certified neurologist, is the medical research director at Phytecs, a biotechnology company that specializes in developing different ways of targeting […]

by

New research conducted by physicians from the University of Texas MD Anderson Cancer Center has revealed that allogeneic adoptive cell therapy (ACT) could have the potential to work effectively and, in 3 patients with different underlying conditions, has appeared to provide a type of “borrowed” immunity that helped clear the virus responsible for progressive multifocal […]

by

About 56 percent of those who returned Amazon goods to a Kohl’s location were new Kohl’s shoppers – or they hadn’t visited Kohl’s at least since July 1, according to the study. That’s higher than in other locations, where less than 43 percent of those visiting were considered new to the chain.(Photo: Justin Sullivan / […]

by

<!–Total Para: 1 Long Para:0 Long Pra Total: 14 Total Para Total: 15–> By Bill Luktisch, Quad-City Times <!–Total Para: 2 Long Para:1 Long Pra Total: 14 Total Para Total: 15–> DES MOINES — Republican Gov. Kim Reynolds has named the acting director of the Iowa Finance Authority to the post full time. <!–Total Para: […]

by

In many ways, Ohio — where medical cannabis finally went on sale to qualified patients on Jan. 16, following a two-year build-up and a four-month delay— is a case study in how not to do medical marijuana. Unless you are one of the state’s 24 licensed cultivators. In that case, you are enjoying the right to sell […]

by

JERUSALEM, Feb. 28, 2019 /PRNewswire/ — Intec Pharma Ltd. (NASDAQ: NTEC) (“Intec” or “the Company”) today announces that Company management will participate at the following upcoming investment conferences in March.  Cowen 39th Annual Health Care ConferenceDate: March 11-13, 2019Company Presentation: Monday, March 11, 2019 at 2:10 pm (Eastern time) Location: Boston Marriott Copley Place, Boston, MAPresenter: […]

by

BNEI BRAK, Israel, Feb. 28, 2019 /PRNewswire/ — Stero Biotechs has received Ethics Committee approval by Israel’s Ministry of Health and will soon enroll the first patients in a ground-breaking study to use CBD to reduce steroids in patients with liver disease. Stero discovered that by introducing CBD to patients treated with steroids on regular basis, as their […]

by

Set to roll out the U.S. market’s first prescription cannabidiol soon, GW Pharmaceutical will be looking to assure doctors that Epidiolex, approved to treat rare forms of epilepsy, is vastly different from off-the-shelf artisan oils at cannabis shops. To that end, GW has hired 66 neurology sales representatives who will target some 5,000 epilepsy specialists in the U.S., […]

by